Qin Xiaoru, Jiang Xiaofei, Yuan Qiyan, Xu Guangli, He Xianzhi
Xiaoru Qin, Department of Cardiology, Zhuhai People's Hospital, Zhuhai Hospital Affiliated with Jinan University, 79 Kangning Road, Zhuhai, 519000 Guangdong Province, China.
Xiaofei Jiang, Department of Cardiology, Zhuhai People's Hospital, Zhuhai Hospital Affiliated with Jinan University, 79 Kangning Road, Zhuhai, 519000 Guangdong Province, China.
Pak J Med Sci. 2022 Mar-Apr;38(3Part-I):632-638. doi: 10.12669/pjms.38.3.4971.
To explore the optimal ablation index (AI) parameters for radiofrequency catheter ablation (RA) for treating atrial fibrillation (AF).
Patients with AF (186) who underwent bilateral PVAI in the Department of Cardiology, Zhuhai People's Hospital, Guangdong Province, from March 2018 to October 2019 and received catheter ablation as first-round treatment, were grouped according to the received AI. Control group included patients (95) who received the recommended AI ablation (350-400 for posterior wall, 400-450 for non-posterior wall). Patients in optimal AI group were ablated with optimal AI (300-330 for posterior wall, 350-380 for non-posterior wall). Recurrence was defined as any AF, atrial tachycardia, or atrial flutter lasting more than 30 seconds without anti-arrhythmic drugs after the 3-month blank period.
Of 186 patients, 66 patients had paroxysmal atrial fibrillation and a mean CHADS-VASc score of 2.83±1.64. Isolation rates of bilateral PVI in both groups were 91.4% and 93.6%, for patients with paroxysmal atrial fibrillation, and 81.7% and 80% for patients with persistent atrial fibrillation (P > 0.05). Left atrial function index (LAFI) decreased under the condition of sinus rhythm at the 3rd and 6th months (P < 0.05). LAFI improvement was significantly better in the optimal AI group than in the control group (P < 0.05). Rates of pain and cough during the ablation, and postoperative gastrointestinal discomfort and use of PPIs were higher in the control group (P < 0.05). The recurrence rate was 14.7% and 14.3% after 12 months of follow-up, respectively, and the difference was not statistically significant (P > 0.05).
Radiofrequency ablation of AF, guided by optimal AI combined with impedance, can minimize atrial injury, prevent atrial failure, promote the recovery of atrial function, reduces intraoperative cough, pain, and postoperative gastrointestinal discomfort and use of PPIs.
探讨用于治疗心房颤动(AF)的射频导管消融术(RA)的最佳消融指数(AI)参数。
2018年3月至2019年10月在广东省珠海市人民医院心内科接受双侧肺静脉隔离消融术(PVAI)且首轮治疗采用导管消融术的186例AF患者,根据所接受的AI进行分组。对照组包括95例接受推荐AI消融的患者(后壁为350 - 400,非后壁为400 - 450)。最佳AI组患者采用最佳AI进行消融(后壁为300 - 330,非后壁为350 - 380)。复发定义为在3个月空白期后,在未使用抗心律失常药物的情况下,任何持续超过30秒的AF、房性心动过速或心房扑动。
186例患者中,66例为阵发性心房颤动,平均CHADS - VASc评分为2.83±1.64。阵发性心房颤动患者两组双侧肺静脉隔离率分别为91.4%和93.6%,持续性心房颤动患者分别为81.7%和80%(P>0.05)。在第3个月和第6个月窦性心律情况下,左心房功能指数(LAFI)下降(P < 0.05)。最佳AI组LAFI改善明显优于对照组(P < 0.05)。对照组消融期间疼痛和咳嗽发生率以及术后胃肠道不适和质子泵抑制剂(PPI)使用情况更高(P < 0.05)。随访12个月后复发率分别为14.7%和14.3%,差异无统计学意义(P>0.05)。
以最佳AI结合阻抗为指导的AF射频消融术,可使心房损伤最小化,预防心房功能衰竭,促进心房功能恢复,减少术中咳嗽、疼痛以及术后胃肠道不适和PPI的使用。